成都先导(688222) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 reached ¥107,382,466.51, representing a year-on-year increase of 54.35%[5] - The net profit attributable to shareholders was ¥13,940,028.65, a significant recovery from a loss of ¥9,393,600 in the same period last year[8] - The net cash flow from operating activities was ¥40,865,611.68, showing a substantial increase of 106.61% compared to the previous year[5] - The weighted average return on equity increased to 1.00%, up by 1.72 percentage points from the previous year[5] - The company reported a significant increase in revenue from its DEL platform, which grew by 49.33% year-on-year[8] - Revenue from the UK subsidiary's project milestone income increased by 78.83% due to favorable exchange rate changes[8] - The basic and diluted earnings per share for the period were both ¥0.03, recovering from a loss of ¥0.02 per share in the same period last year[8] - Operating profit for Q1 2024 was ¥14,495,500.79, compared to an operating loss of ¥11,549,642.89 in Q1 2023[21] - Net profit for Q1 2024 was ¥13,910,097.65, a significant recovery from a net loss of ¥9,294,847.57 in Q1 2023[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,738,571,859.29, reflecting a slight increase of 0.52% from the end of the previous year[6] - Total assets as of Q1 2024 amounted to ¥1,738,571,859.29, slightly up from ¥1,729,558,879.03 in the previous year[17] - Total liabilities decreased to ¥340,243,739.36 from ¥346,566,991.96, a reduction of 1.8%[17] - Shareholders' equity increased to ¥1,398,328,119.93 from ¥1,382,991,887.07, reflecting a growth of 1.1%[17] Research and Development - Research and development (R&D) expenses totaled ¥12,989,221.09, a decrease of 37.09% year-on-year, with R&D expenses accounting for 12.10% of operating revenue, down 17.58 percentage points[6] - Research and development expenses for Q1 2024 were ¥12,989,221.09, down from ¥20,648,543.13 in Q1 2023, indicating a decrease of 37.4%[21] Cash Flow - In Q1 2024, the cash inflow from operating activities totaled $119.23 million, an increase of 13.9% compared to $104.62 million in Q1 2023[25] - The net cash flow from operating activities reached $40.87 million, up 106.5% from $19.78 million in the same period last year[25] - Cash inflow from investment activities was $584.47 million, compared to $547.15 million in Q1 2023, marking a 6.8% increase[25] - The net cash flow from investment activities improved significantly to $56.43 million, compared to a negative $103.31 million in Q1 2023[25] - The cash and cash equivalents at the end of Q1 2024 were $467.11 million, up from $267.06 million at the end of Q1 2023, representing a 75% increase[26] - The total cash outflow from financing activities was $3.04 million, slightly higher than $2.90 million in Q1 2023[26] - The company received $580 million from investment recoveries, an increase from $542 million in the previous year[25] - The cash paid for the purchase of fixed assets and intangible assets was $16.27 million, down from $26.72 million in Q1 2023, indicating a 39% decrease[25] - The company reported a tax refund of $1.92 million in Q1 2024, down from $4.81 million in Q1 2023[25] - The impact of exchange rate changes on cash and cash equivalents was a positive $260,766.14 in Q1 2024, compared to a negative impact of $2.87 million in Q1 2023[26] Shareholder Information - Total number of common shareholders at the end of the reporting period is 14,016[10] - The largest shareholder, JIN LI, holds 81,876,948 shares, representing 20.43% of total shares[10] - The second largest shareholder, Lhasa Economic and Technological Development Zone Huabo Medical Devices Co., Ltd., holds 50,870,579 shares, representing 12.70%[10] Current Assets - Total current assets as of March 31, 2024, amount to RMB 1,190,767,811.78, an increase from RMB 1,181,276,653.89 as of December 31, 2023[15] - Cash and cash equivalents are reported at RMB 473,690,627.37, up from RMB 377,398,358.67[15] - Trading financial assets decreased to RMB 510,083,888.89 from RMB 580,096,583.33[15] - Accounts receivable decreased to RMB 74,631,841.84 from RMB 96,822,078.91[15] - Inventory increased to RMB 30,010,252.14 from RMB 28,177,254.27[15] - Long-term equity investments decreased to RMB 11,449,172.19 from RMB 12,375,393.30[15] Other Comprehensive Income - The company reported a decrease in other comprehensive income, with a net amount of -¥67,452.95 compared to -¥3,250,700.35 in Q1 2023[22]